Hananja Ehf;Gizurarson, Sveinbjorn;Meiri, Hamutal;University Of Iceland
发明人:
GIZURARSON, Sveinbjorn,MEIRI, Hamutal
申请号：
DK11848091
公开号：
DK2651430T3
申请日:
2011.12.14
申请国别(地区):
DK
年份:
2018
代理人:
摘要：
The present invention relates to the biological and pharmacological effects of placental protein 13 (PP-13), an effect that may be used as a treatment and/or prevention of preeclampsia and placental insufficiencies, in pregnant female mammals, especially pregnant women. The invention relates to a method to treat female mammals with the purpose to precondition the uterine arteries and prevent and/or reverse the pathological conditions associated with placental insufficiency such as preeclampsia, HELLP and/or eclampsia.
